GLPwatch
Risk of Gastrointestinal Adverse Events Associated With Glucagon-Like Peptide-1 Receptor Agonists for Weight Loss.
JAMA · 2023
Last updated 2026-05-28| Journal | JAMA, 2023 |
|---|---|
| Citations | 350 |
| Relative citation ratio | 46.54 |
| NIH percentile | 100 |
| Molecules | — |
| Conditions studied | Obesity |
Full record and abstract on PubMed 37796527 ↗